文献速递中医妇科中药与中成药合理使用中医内科

桂枝茯苓方:化学成分、质量控制、药代动力学、药理特性、不良反应及临床应用综述

Guizhi Fuling Formulation: A review on chemical constituents, quality control, pharmacokinetic studies, pharmacological properties, adverse reactions and clinical applications.
PubMed 文献 · J Ethnopharmacol · 2023-10-05

桂枝茯苓方出自《金匮要略》,由桂枝、茯苓、芍药、牡丹皮、桃仁组成,功能活血化瘀、消癥散结,原用于妊娠胎动不安因癥块所致,现扩展用于妇科疾病及宫颈癌、卵巢癌等肿瘤。该综述系统分析其化学成分、质量控制、药代动力学、药理特性、不良反应及临床应用,指出质量控制体系不完善、药代动力学研究不全面、药理机制阐释不足、临床安全性未充分验证等问题,并提出未来研究方向。

要点

  • 桂枝茯苓方有丸、胶囊、片、颗粒、汤剂等多种剂型,临床用于妇科疾病及多种肿瘤。
  • 现有研究存在质量控制体系不完善、药代动力学研究不全面、药理机制阐释不足等问题。
  • 未来应加强质量控制、阐明药理与药代过程、基于大规模临床研究再确认安全性。

核心结论

  • 桂枝茯苓方在药物研究和临床治疗中极具价值,尤其对妇科疾病,但存在质量控制、药理与药代、临床安全性等方面的问题。

研究设计与样本

  • 综述类研究,检索范围包括中医经典书籍及中国知网、万方、PubMed、SpringerLink、Web of Science、Google Scholar等数据库。

主要发现

  • 桂枝茯苓方存在质量控制体系不完善、药代动力学研究不全面、药理机制阐释不足、临床安全性未充分验证等问题。

临床怎么用

  • 临床可用于妇科疾病及宫颈癌、卵巢癌等肿瘤,但需注意不同剂型的选择及安全性尚未充分验证。

局限性

  • 质量控制体系不完善,药代动力学研究不全面,药理机制阐释不足,临床安全性未充分验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Guizhi Fuling Formulation (GF), composed of Cinnamomi Ramulus, Poria, Paeoniae Radix, Moutan Cortex, and Persicae Semen, was first recorded as a pill in the Traditional Chinese Medicine (TCM) classical book Synopsis of Prescriptions of the Golden Chamber written by Zhang Zhongjing in the Eastern Han Dynasty (25-220 CE). As a TCM prescription, it functions to improve blood circulation, reduce blood stasis and eliminate abdominal lumps. Originally used to treat the restlessness of pregnancy due to a mass, it is now also effective in treating gynecological illnesses and various tumors such as cervical cancer, ovarian cancer, and others. With the expansion of clinical applications, GF was developed into different dosage forms, including Guizhi Fuling Pill (GFP), Guizhi Fuling Capsule (GFC), Guizhi Fuling Tablet (GFT), Guizhi Fuling Granule (GFG), and Guizhi Fuling Decoction (GFD). Different dosage forms of GF play an important role in clinical treatment. AIM OF THE REVIEW: To systematically analyze and summarize the research findings concerning the chemical constituents, quality control, pharmacokinetic studies, pharmacological properties, adverse reactions, and clinical applications of GF, so as to point out the problems existing in the current research and provides opinions for future study. MATERIALS AND METHODS: The relevant literatures were collected from classical TCM books and a variety of databases, including China National Knowledge Infrastructure, WanFang Data, PubMed, SpringerLink, Web of Science, and Google Scholar. All eligible studies are analyzed and summarized in this review. RESULTS: There are some problems for GF: the quality control system is not perfect, the study of pharmacokinetics is not comprehensive, the explanation of pharmacological mechanism is insufficient, and the clinical safety has not been fully verified. A few of research directions for future research are proposed: (i) to establish the method of characteristic components combined with bioassay and multi-index content determination to improve the quality evaluation; (ii) to elucidate pharmacokinetic studies based on human pharmacokinetic characteristics and interaction with intestinal microbiota; (iii) to carry out pharmacological mechanism studies at whole, organ, cellular and molecular levels; (iv) to reconfirm safety of various dosage forms of GF based on large-scale clinical studies. CONCLUSIONS: GF is extremely valuable in drug research and in clinical treatment especially for gynecological diseases. However, there are also some issues. Future efforts should focus on strengthening quality control, clarifying pharmacological and pharmacokinetic processes, and reconfirming clinical safety.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Liu X, Chen L, Sun P, et al. Guizhi Fuling Formulation: A review on chemical constituents, quality control, pharmacokinetic studies, pharmacological properties, adverse reactions and clinical applications. J Ethnopharmacol. 2023. PMID: 37802375. doi:10.1016/j.jep.2023.117277

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。